Balance Sheet - Astera Labs, Inc. (ALAB)
$ (Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | |
|---|---|---|---|---|
| Total cash and short-term investments | 1,188.82 | 914.30 | 149.31 | 163.14 |
| Accounts receivable, net | 83.20 | 38.81 | 8.34 | 10.72 |
| Inventories | 58.98 | 43.22 | 24.10 | 28.87 |
| Other current assets | 31.03 | 16.65 | 4.06 | 3.27 |
| Total current assets | 1,362.03 | 1,012.98 | 185.81 | 206.01 |
| Total non-current assets | 169.79 | 41.53 | 10.49 | 5.73 |
| Total assets | 1,531.82 | 1,054.51 | 196.29 | 211.73 |
| Total current liabilities | 133.04 | 86.54 | 35.08 | 40.09 |
| Total non-current liabilities | 35.15 | 3.17 | 3.79 | 256.93 |
| Total liabilities | 168.19 | 89.71 | 38.87 | 297.02 |
| Total stockholders' equity | 1,363.63 | 964.80 | 157.43 | -85.29 |
| Common shares outstanding | 180 | 131 | 153 | 130 |
Show Quarterly Balance Sheet
Balance Sheet - Astera Labs, Inc. (ALAB)
$ (Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 1,184.47 | 1,188.82 | 1,134.43 | 1,065.09 | 924.73 | 914.30 | 886.80 | 831.00 | 801.39 | 149.31 | 0.00 | 0.00 | 163.14 | 163.14 | 0.00 | 0.00 | 0.00 |
| Accounts receivable, net | 134.80 | 83.20 | 42.90 | 24.32 | 69.78 | 38.81 | 25.39 | 22.23 | 16.76 | 8.34 | 10.72 | ||||||
| Inventories | 60.16 | 58.98 | 51.66 | 58.60 | 51.06 | 43.22 | 24.42 | 28.57 | 29.57 | 24.10 | 28.87 | ||||||
| Other current assets | 33.51 | 31.03 | 61.17 | 32.74 | 30.26 | 16.65 | 8.99 | 9.45 | 6.73 | 4.06 | -163.14 | 3.27 | |||||
| Total current assets | 1,412.94 | 1,362.03 | 1,290.16 | 1,180.75 | 1,075.82 | 1,012.98 | 945.59 | 891.25 | 854.44 | 185.81 | 163.14 | 206.01 | |||||
| Total non-current assets | 246.28 | 169.79 | 111.02 | 90.66 | 45.88 | 41.53 | 37.48 | 24.27 | 10.46 | 10.49 | -163.14 | 5.73 | |||||
| Total assets | 1,659.22 | 1,531.82 | 1,401.18 | 1,271.41 | 1,121.69 | 1,054.51 | 983.07 | 915.52 | 864.90 | 196.29 | 211.73 | ||||||
| Total current liabilities | 125.04 | 133.04 | 100.96 | 106.38 | 77.28 | 86.54 | 88.04 | 64.07 | 45.59 | 35.08 | 40.09 | ||||||
| Total non-current liabilities | 40.22 | 35.15 | 28.49 | 29.31 | 2.85 | 3.17 | 5.41 | 6.19 | 10.53 | 258.91 | -169.84 | 1.81 | |||||
| Total liabilities | 165.27 | 168.19 | 129.45 | 135.69 | 80.13 | 89.71 | 93.45 | 70.26 | 56.12 | 293.99 | -169.84 | 41.90 | |||||
| Total stockholders' equity | 1,493.95 | 1,363.63 | 1,271.73 | 1,135.71 | 1,041.56 | 964.80 | 889.61 | 845.25 | 808.78 | -97.70 | 169.84 | 169.84 | |||||
| Common shares outstanding | 181 | 181 | 181 | 178 | 178 | 178 | 157 | 155 | 154 | 153 | 153 | 130 | 130 | 34 | 34 | 34 | 34 |